Sumitomo Dainippon Pharma Co (DPM) Ratios
Sumitomo Dainippon Pharma Co Ratios
DE:DPM's free cash flow for Q3 2026 was $22.96B. For the 2026 fiscal year, DE:DPM's free cash flow was decreased by $-1.29B and operating cash flow was $24.24B. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 26 | Mar 25 | Mar 24 | Mar 23 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.05 | 1.03 | 0.52 | 1.02 | 1.79 |
| Quick Ratio | 0.66 | 0.71 | 0.30 | 0.77 | 1.44 |
| Cash Ratio | 0.10 | 0.16 | 0.06 | 0.38 | 0.73 |
| Solvency Ratio | 0.09 | 0.25 | -0.37 | -0.05 | 0.15 |
| Operating Cash Flow Ratio | 0.07 | 0.26 | -0.47 | 0.03 | 0.11 |
| Short-Term Operating Cash Flow Coverage | 0.36 | 1.88 | -0.85 | 0.13 | 1.25 |
| Net Current Asset Value | $ -319.96B | $ -232.85B | $ -481.80B | $ -346.10B | $ -134.92B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.42 | 0.27 | 0.46 | 0.31 | 0.22 |
| Debt-to-Equity Ratio | 1.85 | 0.74 | 2.68 | 0.85 | 0.47 |
| Debt-to-Capital Ratio | 0.65 | 0.43 | 0.73 | 0.46 | 0.32 |
| Long-Term Debt-to-Capital Ratio | 0.60 | 0.38 | 0.46 | 0.38 | 0.29 |
| Financial Leverage Ratio | 4.38 | 2.75 | 5.81 | 2.79 | 2.15 |
| Debt Service Coverage Ratio | 1.05 | 2.85 | -0.94 | -0.56 | 2.91 |
| Interest Coverage Ratio | 2.62 | 4.94 | -82.81 | -24.37 | 19.75 |
| Debt to Market Cap | 1.05 | 0.26 | 2.60 | 1.04 | 0.56 |
| Interest Debt Per Share | 812.51 | 572.32 | 1065.11 | 879.78 | 723.88 |
| Net Debt to EBITDA | 5.63 | 1.32 | -1.39 | -58.00 | 0.66 |
| Profitability Margins | |||||
| Gross Profit Margin | 56.51% | 56.67% | 59.76% | 67.79% | 71.94% |
| EBIT Margin | 6.56% | 24.39% | -101.36% | -8.06% | 15.36% |
| EBITDA Margin | 12.97% | 28.97% | -89.35% | -0.63% | 22.21% |
| Operating Profit Margin | 5.62% | 11.11% | -112.60% | -13.86% | 10.76% |
| Pretax Profit Margin | 4.42% | 22.14% | -102.72% | -8.63% | 14.81% |
| Net Profit Margin | 5.93% | 23.58% | -100.13% | -13.41% | 10.07% |
| Continuous Operations Profit Margin | 5.93% | 23.58% | -100.12% | -17.41% | 7.25% |
| Net Income Per EBT | 134.20% | 106.50% | 97.48% | 155.49% | 68.00% |
| EBT Per EBIT | 78.54% | 199.33% | 91.23% | 62.25% | 137.73% |
| Return on Assets (ROA) | 3.18% | 13.28% | -34.71% | -6.57% | 4.31% |
| Return on Equity (ROE) | 13.95% | 36.54% | -201.82% | -18.32% | 9.28% |
| Return on Capital Employed (ROCE) | 4.47% | 9.44% | -90.35% | -10.10% | 5.85% |
| Return on Invested Capital (ROIC) | 4.06% | 8.81% | -50.67% | -8.98% | 2.78% |
| Return on Tangible Assets | 6.34% | 24.68% | -61.51% | -12.50% | 7.90% |
| Earnings Yield | 8.16% | 12.96% | -195.27% | -23.15% | 11.75% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.13 | 3.37 | 3.23 | 5.79 | 3.70 |
| Payables Turnover | 4.50 | 3.46 | 1.87 | 13.35 | 7.00 |
| Inventory Turnover | 1.84 | 2.30 | 1.10 | 1.90 | 1.59 |
| Fixed Asset Turnover | 8.55 | 10.25 | 5.43 | 9.43 | 8.74 |
| Asset Turnover | 0.54 | 0.56 | 0.35 | 0.49 | 0.43 |
| Working Capital Turnover Ratio | -3.42 | 44.62 | -2.66 | 4.82 | 2.78 |
| Cash Conversion Cycle | 188.30 | 161.82 | 250.18 | 228.26 | 276.54 |
| Days of Sales Outstanding | 71.13 | 108.45 | 112.83 | 63.01 | 98.68 |
| Days of Inventory Outstanding | 198.27 | 158.74 | 332.63 | 192.59 | 230.02 |
| Days of Payables Outstanding | 81.11 | 105.37 | 195.28 | 27.34 | 52.16 |
| Operating Cycle | 269.40 | 267.19 | 445.46 | 255.60 | 328.70 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 41.53 | 180.51 | -608.85 | 30.05 | 78.63 |
| Free Cash Flow Per Share | 20.14 | 168.91 | -648.45 | -2.03 | 44.66 |
| Dividend Paid and CapEx Coverage Ratio | 1.94 | 15.55 | -13.06 | 0.50 | 1.27 |
| Capital Expenditure Coverage Ratio | 1.94 | 15.56 | -15.38 | 0.94 | 2.32 |
| Operating Cash Flow Coverage Ratio | 0.05 | 0.33 | -0.58 | 0.03 | 0.11 |
| Operating Cash Flow to Sales Ratio | 0.04 | 0.16 | -0.77 | 0.02 | 0.06 |
| Free Cash Flow Yield | 2.76% | 8.14% | -159.72% | -0.25% | 3.70% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 12.25 | 7.72 | -0.51 | -4.32 | 8.51 |
| Price-to-Sales (P/S) Ratio | 0.73 | 1.82 | 0.51 | 0.58 | 0.86 |
| Price-to-Book (P/B) Ratio | 1.71 | 2.82 | 1.03 | 0.79 | 0.79 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 36.19 | 12.29 | -0.63 | -399.76 | 27.05 |
| Price-to-Operating Cash Flow Ratio | 17.55 | 11.50 | -0.67 | 26.96 | 15.36 |
| Price-to-Earnings Growth (PEG) Ratio | -0.11 | 0.02 | -0.00 | 0.02 | 24.57 |
| Enterprise Value Multiple | 11.23 | 7.60 | -1.96 | -150.00 | 4.52 |
| Enterprise Value | 580.75B | 997.45B | 551.14B | 524.70B | 561.49B |
| EV to EBITDA | 11.23 | 7.60 | -1.96 | -150.00 | 4.52 |
| EV to Sales | 1.46 | 2.20 | 1.75 | 0.94 | 1.00 |
| EV to Free Cash Flow | 72.58 | 14.86 | -2.14 | -651.80 | 31.64 |
| EV to Operating Cash Flow | 35.20 | 13.91 | -2.28 | 43.96 | 17.97 |
| Tangible Book Value Per Share | -504.51 | -199.11 | -602.33 | -332.12 | 200.69 |
| Shareholders’ Equity Per Share | 426.59 | 736.16 | 392.82 | 1023.80 | 1530.07 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.34 | -0.06 | 0.03 | -1.02 | 0.51 |
| Revenue Per Share | 1003.88 | 1140.97 | 791.76 | 1398.33 | 1409.63 |
| Net Income Per Share | 59.49 | 268.99 | -792.79 | -187.55 | 141.99 |
| Tax Burden | 1.34 | 1.06 | 0.97 | 1.55 | 0.68 |
| Interest Burden | 0.67 | 0.91 | 1.01 | 1.07 | 0.96 |
| Research & Development to Revenue | 0.13 | 0.10 | 0.36 | 0.24 | 0.17 |
| SG&A to Revenue | 0.40 | 0.36 | 1.37 | 0.50 | 0.32 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.70 | 0.67 | 0.77 | -0.12 | 0.77 |
Currency in JPY